DDX41 is the most frequently mutated gene in myeloid neoplasms associated with germline predisposition including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We analyzed 3795 patients with myeloid neoplasms and identified 151 (4%) with DDX41 variants and a diagnosis of AML (n = 96), MDS (n = 52), and chronic myelomonocytic leukemia (n = 3). The most frequent DDX41 variants were the somatic variant p.R525H, followed by the germline variants p.M1I and p.D140fs. Most neoplasms had a normal karyotype (59%) and the most frequent co-mutations were TP53 (16%) and ASXL1 (15%). 30% of patients had no concomitant mutations besides DDX41 mutation. Patients with myeloid malignancies and DDX41 variants responded well to therapy, with an overall response rate for patients with treatment naïve AML and MDS of 87% and 84%, respectively. The median overall survival (mOS) of patients with treatment-naïve AML or MDS was 49 and 71 months, respectively. Patients with AML treated with low-intensity regimens including venetoclax had an improved survival (2-year OS 91% vs. 60%, p = .02) and lower cumulative incidence of relapse compared to those treated without venetoclax (10% vs. 56%, p = .03). In the 33% of patients receiving hematopoietic stem cell transplantation, the 2-year OS was 80% and 85% for AML and MDS, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajh.27070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding.
Curr Opin Hematol
November 2024
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center.
Purpose Of Review: DDX41 mutations are the most common cause of germline predisposition to adult-onset myeloid neoplasms. The unique mutational landscape and clinical features indicate a distinct molecular pathogenesis, but the precise mechanism by which DDX41 mutations cause disease is poorly understood, owing to the multitude of DDX41 functions. In this review, we will update DDX41's known functions, present unique clinical features and treatment considerations, and summarize the current understanding of the molecular pathogenesis of the disease.
View Article and Find Full Text PDFGenome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts.
Leukemia
November 2024
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Article Synopsis
- About 10% of people with myeloid malignancies have a genetic predisposition, and a study used a genome-first approach to investigate this.
- They analyzed eight specific genes associated with myeloid malignancy risk in a large sample of individuals from two databases, discovering high odds of developing these cancers and reduced survival rates among those with harmful genetic variants.
- The most frequently found variant was in the DDX41 gene, which dramatically increased the likelihood of developing myeloid malignancies and also raised the risk of overall mortality among those affected.
Deleterious germline variants constitute the most common inherited predisposition disorder linked to myeloid neoplasms (MNs). The role of DDX41 in hematopoiesis and how its germline and somatic mutations contribute to MNs remain unclear. Here we show that DDX41 is essential for erythropoiesis but dispensable for the development of other hematopoietic lineages.
View Article and Find Full Text PDFBiallelic germline DDX41 variants in a patient with bone dysplasia, ichthyosis, and dysmorphic features.
Hum Genet
December 2024
NIH Undiagnosed Diseases Program, Common Fund, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Article Synopsis
- * A patient with compound heterozygous DDX41 variants exhibited symptoms including bone dysplasia and ichthyosis, and analysis of their skin cells showed reduced DDX41 levels and disruption of immune gene activation.
- * Further studies revealed significant gene dysregulation and increased periostin mRNA in the patient’s cells, indicating that impaired DDX41 function and altered periostin expression likely contribute to the patient's complex disorder.
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes.
Leuk Res
November 2024
Centre for Cancer Biology, Alliance between SA Pathology and University of South Australia, Adelaide, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia.
Epidemiological evidence of familial predispositions to myeloid malignancies and myeloproliferative neoplasms (MPN) has long been recognised, but recent studies have added to knowledge of specific germline variants in multiple genes that contribute to the familial risk. These variants may be common risk alleles in the general population but have low penetrance and cause sporadic MPN, such as the JAK2 46/1 haplotype, the variant most strongly associated with MPN. Association studies are increasingly identifying other MPN susceptibility genes such as TERT, MECOM, and SH2B3, while some common variants in DDX41 and RUNX1 appear to lead to a spectrum of myeloid malignancies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!